Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to

George Karayannis1, George Kitsios, Haralambos Kotidis

  • 1Department of Cardiology, University of Thessaly Medical School, Larissa University Hospital, P.O. Box 1425, 411 10 Larissa, Greece.

Heart Failure Reviews
|April 24, 2007
PubMed

Insights

Left atrial remodeling, including dilation and systolic dysfunction, is a key factor in the progression from asymptomatic left ventricular dysfunction to symptomatic systolic heart failure (HF). This process contributes to pulmonary congestion and neurohormonal activation characteristic of symptomatic HF.

Area of Science:

  • Cardiology
  • Physiology
  • Pathophysiology

Background:

  • Systolic heart failure (HF) progresses from asymptomatic left ventricular (LV) dysfunction to symptomatic disease.
  • LV remodeling and neurohormonal activation accompany symptomatic HF progression.
  • Mechanisms of symptom development in HF remain unclear, potentially independent of hemodynamics.

Purpose of the Study:

  • To review evidence supporting the role of left atrial remodeling in the progression to symptomatic systolic HF.
  • To elucidate the contribution of left atrial dysfunction to HF symptom development.

Main Methods:

  • Narrative review of experimental and clinical evidence.
  • Analysis of the mechanical, endocrine, and regulatory functions of the left atrium.
  • Examination of the relationship between left atrial remodeling and HF progression.

Main Results:

  • Left atrial dilation and systolic dysfunction (remodeling) are identified as contributors to symptomatic HF.
  • Left atrial remodeling precedes and facilitates pulmonary congestion and neurohormonal activation.
  • Left atrial remodeling is a prerequisite for the development of symptomatic systolic HF.

Conclusions:

  • Left atrial remodeling plays a critical role in the transition from asymptomatic LV dysfunction to symptomatic systolic HF.
  • Understanding left atrial remodeling offers insights into HF pathophysiology and potential therapeutic targets.
  • The left atrium's functions are integral to the development and manifestation of chronic symptomatic systolic HF.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...